Skip to content
healthcare.dev

ERLOTINIB HYDROCHLORIDE

NDC 62332-565, ERLOTINIB HYDROCHLORIDE, tablet, film coated, from Alembic Pharmaceuticals Inc..

Product NDC
62332-565
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214719
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERLOTINIB HYDROCHLORIDE25 mg/1

Pharmacologic classes

Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]

Package NDCNDC-11Package
62332-565-306233205653030 TABLET, FILM COATED in 1 BOTTLE (62332-565-30)
62332-565-906233205659090 TABLET, FILM COATED in 1 BOTTLE (62332-565-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ccf1e415-4980-462f-8ac2-87979bda149e

Use it

Look up 62332-565 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-565 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-565. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.